IL88275A0 - L-proline derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

L-proline derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL88275A0
IL88275A0 IL88275A IL8827588A IL88275A0 IL 88275 A0 IL88275 A0 IL 88275A0 IL 88275 A IL88275 A IL 88275A IL 8827588 A IL8827588 A IL 8827588A IL 88275 A0 IL88275 A0 IL 88275A0
Authority
IL
Israel
Prior art keywords
derivatives
group
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL88275A
Other languages
English (en)
Original Assignee
Inorgan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inorgan Sa filed Critical Inorgan Sa
Publication of IL88275A0 publication Critical patent/IL88275A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Protection Of Transformers (AREA)
  • Measurement Of Force In General (AREA)
IL88275A 1987-11-03 1988-11-03 L-proline derivatives,their preparation and pharmaceutical compositions containing them IL88275A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8715228A FR2622581B1 (fr) 1987-11-03 1987-11-03 Nouveaux derives de l-proline, leur preparation et leurs applications biologiques

Publications (1)

Publication Number Publication Date
IL88275A0 true IL88275A0 (en) 1989-06-30

Family

ID=9356437

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88275A IL88275A0 (en) 1987-11-03 1988-11-03 L-proline derivatives,their preparation and pharmaceutical compositions containing them

Country Status (12)

Country Link
US (1) US5212158A (de)
EP (1) EP0316218B1 (de)
JP (1) JP2694191B2 (de)
KR (1) KR0121793B1 (de)
AT (1) ATE94560T1 (de)
CA (1) CA1340227C (de)
DE (1) DE3884139T2 (de)
ES (1) ES2061710T3 (de)
FI (1) FI885083A (de)
FR (1) FR2622581B1 (de)
IE (1) IE64509B1 (de)
IL (1) IL88275A0 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445606B1 (de) * 1990-02-27 1997-01-22 The Agency of Industrial Science and Technology Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
JP3343181B2 (ja) * 1995-09-20 2002-11-11 生化学工業株式会社 桂皮酸誘導体
US7671029B2 (en) 1999-08-06 2010-03-02 Immupharma Sa Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances
US20030060413A1 (en) * 2001-09-06 2003-03-27 Zimmer Robert H. Derivatives of pseudo-peptides, their preparation and their biological uses
US6908900B2 (en) * 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
DE10105040A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
US20050192228A1 (en) * 2001-02-05 2005-09-01 Jean Rapin Tripeptide derivatives for the treatment of neurodegenerative diseases
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105038B4 (de) * 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105039A1 (de) * 2001-02-05 2002-08-08 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US7252446B2 (en) * 2004-03-31 2007-08-07 Brother Kogoy Kabushiki Kaisha Image forming apparatus
FR2932179B1 (fr) * 2008-06-09 2012-12-07 I R D Procede microbiologique de synthese de derives cinnamoyl amides d'acides amines
UY32827A (es) * 2009-08-12 2011-02-28 Glaxo Group Ltd Inhibidores de catepsina c
CA2827157A1 (en) 2011-02-11 2012-08-16 Glaxosmithkline Intellectual Property Development Limited Cathepsin c inhibitors
US20160045473A1 (en) * 2012-08-01 2016-02-18 Rory Powell Blake Biological Basis Of Adult Wellness
US20150038547A1 (en) * 2013-07-31 2015-02-05 Rory Powell Blake Biological Basis of Adult Wellness

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4260682A (en) * 1979-04-04 1981-04-07 Ryan James W High sensitivity assays for angiotensin converting enzyme
JPS57501234A (de) * 1980-08-25 1982-07-15
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
EP0124317B1 (de) * 1983-04-27 1990-04-11 Ici Americas Inc. Prolin-Derivate
JPS63112597A (ja) * 1986-10-29 1988-05-17 Tokuyama Soda Co Ltd アミノ酸誘導体
US4804743A (en) * 1987-01-29 1989-02-14 Warner-Lambert Copmany Proline-containing renin inhibitors

Also Published As

Publication number Publication date
JPH01157998A (ja) 1989-06-21
IE883321L (en) 1989-05-03
CA1340227C (fr) 1998-12-15
ES2061710T3 (es) 1994-12-16
EP0316218A1 (de) 1989-05-17
FI885083A0 (fi) 1988-11-03
KR890008091A (ko) 1989-07-08
US5212158A (en) 1993-05-18
FR2622581A1 (fr) 1989-05-05
IE64509B1 (en) 1995-08-09
JP2694191B2 (ja) 1997-12-24
DE3884139T2 (de) 1994-05-05
FI885083A (fi) 1989-05-04
EP0316218B1 (de) 1993-09-15
ATE94560T1 (de) 1993-10-15
KR0121793B1 (ko) 1997-11-27
FR2622581B1 (fr) 1990-02-16
DE3884139D1 (de) 1993-10-21

Similar Documents

Publication Publication Date Title
IL88275A0 (en) L-proline derivatives,their preparation and pharmaceutical compositions containing them
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
DE3069813D1 (en) Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation
ITMI910404A1 (it) Derivati poli-4-aminopirrol-2-carbossiamidici, processi di preparazione e composizioni farmaceutiche che li contengono
NO812355L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater
DE3561819D1 (en) Derivatives of methylenediphosphonic acid, process for their preparation and antirheumatic pharmaceutical compositions containing them
IL64647A (en) 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ZA912618B (en) 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them
ATE116647T1 (de) Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
HUT50142A (en) Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
IL87796A0 (en) Substituted 3-aminosydnonimines,their preparation and pharmaceutical compositions containing them
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUT53093A (en) Process for producing substituted 3-amino-sidnonimine derivatives and pharmaceutical compositions them as active components
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
IT1248068B (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
HU9702541D0 (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
EXP Patent expired